home / stock / mdwd / mdwd articles

MDWD Articles, MediWound Ltd.

Stock Information
Company Name: MediWound Ltd.
Stock Symbol: MDWD
Market: NASDAQ
Website: mediwound.com
Menu
MDWD MDWD Quote MDWD Short MDWD News MDWD Articles MDWD Message Board
Get MDWD Alerts

News, Short Squeeze, Breakout and More Instantly...
MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program | Benzinga

Funds to be used for clinical development of EscharEx® to treat diabetic foot ulcers (DFUs) Award advances MediWound's DFU program and i...
MediWound Announces $25 Million Strategic Private Placement Financing | Benzinga

YAVNE, Israel, July 15, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), the world leader in next-generation enzymatic therapeutics for ti...

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has resigned as the Chief ...

US Stocks Mixed; Jobs Figures Top Estimates For June | Benzinga

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 50 points on Friday. Following the market opening Friday, the Do...
Why Sharps Technology Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it received two purchas...

MediWound to Report Fourth Quarter and Full Year 2023 Financial Results | Benzinga

YAVNE, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), the global leader in next-generation enzymatic therapeutics for ...

Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development | Benzinga

Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S. Department of Defense (DoD), through the Medical Technology...
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army | Benzinga

YAVNE, Israel, Dec. 28, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company focused on next-gene...

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer | Benzinga

YAVNE, Israel, Nov. 21, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company focused on next-gene...

MediWound to Report Third Quarter 2023 Financial Results | Benzinga

YAVNE, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), the global leader in next-generation enzymatic therapeutics for t...
Next 10